XML 15 R5.htm IDEA: XBRL DOCUMENT v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Total
Common stock
Additional paid-in capital
Accumulated deficit
Beginning balance (shares) at Dec. 31, 2020   43,205,221    
Beginning balance at Dec. 31, 2020 $ 37,493 $ 4 $ 603,685 $ (566,196)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) (20,550)     (20,550)
Exercise of options, vesting of restricted stock units and shares issued under employee stock purchase plan (in shares)   129,102    
Exercise of options, vesting of restricted stock units and shares issued under employee stock purchase plan 388   388  
Stock-based compensation 2,442   2,442  
Issuance of common stock, net of issuance costs (in shares)   8,052,273    
Issuance of common stock, net of issuance costs 73,128 $ 1 73,127  
Ending balance (shares) at Mar. 31, 2021   51,386,596    
Ending balance at Mar. 31, 2021 $ 92,901 $ 5 679,642 (586,746)
Beginning balance (shares) at Dec. 31, 2021 53,577,744 53,577,744    
Beginning balance at Dec. 31, 2021 $ 48,636 $ 5 688,156 (639,525)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net income (loss) 4,670     4,670
Stock-based compensation 893   893  
Vesting of restricted stock units, net of witholding tax (in shares)   75,297    
Vesting of restricted stock units, net of withholding tax $ (25)   (25)  
Issuance of commitment shares (in shares) 1,667,593      
Issuance of common stock, net of issuance costs (in shares)   2,587,855    
Issuance of common stock, net of issuance costs $ 1,557 $ 1 1,556  
Ending balance (shares) at Mar. 31, 2022 57,908,489 57,908,489    
Ending balance at Mar. 31, 2022 $ 55,731 $ 6 $ 690,580 $ (634,855)